Gene · 146433
Papers1,864
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,864
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease. | Rheumatology (Oxford) | 2025 | 38830088 | PubTator, text mining | PubMed |
| Excitatory Neuron-Derived Interleukin-34 Controls Cortical Developmental Microglia Function. | bioRxiv | 2025 | 38766127 | PubTator, text mining | PubMed |
| Higher Intraocular Levels of Inflammatory Factors are Related to Retinal Vascular and Neurodegeneration in Myopic Retinopathy. | J Inflamm Res | 2024 | 39677296 | PubTator, text mining | PubMed |
| Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen-processing-presentation machinery and poor patient survival. | Clin Transl Immunology | 2024 | 39619016 | PubTator, text mining | PubMed |
| Is there a relationship between CSF Interleukin 34 Level and clinicoradiological activity and IgG index in patients with MS? | Mult Scler Relat Disord | 2024 | 39571220 | PubTator, text mining | PubMed |
| TAM-ing the beast with IL-34 blockade. | Sci Immunol | 2024 | 39485858 | PubTator, text mining | PubMed |
| Molecular landscape of the overlap between Alzheimer's disease and somatic insulin-related diseases. | Alzheimers Res Ther | 2024 | 39465382 | PubTator, text mining | PubMed |
| The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas. | Cancers (Basel) | 2024 | 39456618 | PubTator, text mining | PubMed |
| Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut. | Cells | 2024 | 39451216 | PubTator, text mining | PubMed |
| AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization. | J Immunother Cancer | 2024 | 39448199 | PubTator, text mining | PubMed |
| Oral and Gingival Crevicular Fluid Biomarkers for Jawbone Turnover Diseases: A Scoping Review. | Diagnostics (Basel) | 2024 | 39410587 | PubTator, text mining | PubMed |
| Expression of Macrophage Colony-Stimulating Factor CSF-1 in Spinal Cord Neurons in Mice with Experimental Autoimmune Encephalomyelitis. | Bull Exp Biol Med | 2024 | 39352675 | PubTator, text mining | PubMed |
| Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. | Immunity | 2024 | 39321806 | PubTator, text mining | PubMed |
| Time series analysis combined with transcriptome sequencing to explore characteristic genes and potential molecular mechanisms associated with ultrasound-guided microwave ablation of glioma. | Int J Hyperthermia | 2024 | 39317933 | PubTator, text mining | PubMed |
| Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer's disease ligands. | Res Sq | 2024 | 39315272 | PubTator, text mining | PubMed |
| Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research. | J Vis Exp | 2024 | 39311620 | PubTator, text mining | PubMed |
| Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity. | Sci Immunol | 2024 | 39241057 | PubTator, text mining | PubMed |
| Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma. | Cancer Lett | 2024 | 39127339 | PubTator, text mining | PubMed |
| Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis. | Front Immunol | 2024 | 39108259 | PubTator, text mining | PubMed |
| IL-34 and its receptors as predictors of brain metastasis and prognosis in lung adenocarcinoma: Unveiling insights through bioinformatic and immunohistochemical investigations. | Heliyon | 2024 | 39055827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/146433/papers?page=7